Bone scan positivity in non-metastatic, castrate-resistant prostate cancer: external validation study
ashley johnston
International braz j urol, 2020
View PDFchevron_right
Predicting bone scan positivity in non-metastatic castration-resistant prostate cancer
Daniel Moreira
Prostate Cancer and Prostatic Diseases, 2015
View PDFchevron_right
Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial
Michael Carducci
JAMA oncology, 2018
View PDFchevron_right
Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer
Josef Fox
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012
View PDFchevron_right
Practice Patterns and Predictors of Followup Imaging after a Negative Bone Scan in Men with Castration Resistant Prostate Cancer: Results from the SEARCH Database
Daniel Moreira
The Journal of urology, 2014
View PDFchevron_right
When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available Guidelines and Proposal of a Novel Risk Stratification Tool
Maria Picchio
European Urology, 2010
View PDFchevron_right
The value of bone scans to predict survival time in patients with diagnosed prostate cancer: single-center retrospective study
Doğangün Yüksel
Journal of Radiology and Oncology
View PDFchevron_right
Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients
Arun Singh
International Journal of Radiation Oncology Biology Physics, 2000
View PDFchevron_right
Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421
David Quinn
Cancer Treatment and Research Communications, 2018
View PDFchevron_right
Application of bone scans for prostate cancer staging: Which guideline shows better result?
Ari chong
Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2014
View PDFchevron_right
Bone Scan Index and Progression-free Survival Data for Progressive Metastatic Castration-resistant Prostate Cancer Patients Who Received ODM-201 in the ARADES Multicentre Study
John Aspegren
European Urology Focus, 2016
View PDFchevron_right
Bone-related Parameters are the Main Prognostic Factors for Overall Survival in Men with Bone Metastases from Castration-resistant Prostate Cancer
Neal Shore, Lawrence Karsh
European urology, 2014
View PDFchevron_right
Automated bone scan index as predictors of survival in prostate cancer
Budi Darmawan,SE
World Journal of Nuclear Medicine, 2017
View PDFchevron_right
Scintigraphic load of bone disease evaluated by DASciS software as a survival predictor in metastatic castration-resistant prostate cancer patients candidates to 223RaCl treatment
MARIA IPPOLITI
Radiology and Oncology
View PDFchevron_right
Survival Rate Estimation of Advanced Carcinoma Prostate Patients by using Bone Scan Quantitative Parameters
iris publishers
Iris Publishers LLC, 2019
View PDFchevron_right
Assessment of Skeletal Tumor Load in Metastasized Castration-Resistant Prostate Cancer Patients: A Review of Available Methods and an Overview on Future Perspectives
Gianmario Sambuceti
Bioengineering, 2018
View PDFchevron_right
Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the royal marsden hospital
R. Thurairaja
BJU International, 2004
View PDFchevron_right
Radiographic Progression-Free Survival As a Response Biomarker in Metastatic Castration-Resistant Prostate Cancer: COU-AA-302 Results
Vahid Naini
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015
View PDFchevron_right
A Novel Automated Platform for Quantifying the Extent of Skeletal Tumour Involvement in Prostate Cancer Patients Using the Bone Scan Index
Hans Lilja
2012
View PDFchevron_right
Identification of subgroups of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone plus prednisone at low vs. high risk of radiographic progression: An analysis of COU-AA-302
Narhari Timilshina
Canadian Urological Association Journal
View PDFchevron_right
Prognostic Implication of Positive Area on Bone Scans (%PAB-Quantitative Parameter) in Bones of Patients with metastatic Prostate cancer
iris publishers
Iris Publishers LLC, 2019
View PDFchevron_right
The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE’s “M1|RT Comparison”
Noel Clarke
European Urology Oncology, 2020
View PDFchevron_right
Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohort
Paul Kil
European Journal of Cancer, 2012
View PDFchevron_right
Bone Scan Overuse in Staging of Prostate Cancer: An Analysis of a Veterans Affairs Cohort
Lorna Kwan
Urology, 2011
View PDFchevron_right
A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index
Steven Larson
Clinical cancer research : an official journal of the American Association for Cancer Research, 1998
View PDFchevron_right
Evaluation of usage of bone scan index in assessment of metastatic prostate cancer
Adel Brčaninović
2021
View PDFchevron_right
A prospective study to evaluate the intra-individual reproducibility of bone scans for quantitative assessment in patients with metastatic prostate cancer
Reza Kaboteh
BMC medical imaging, 2018
View PDFchevron_right
Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? A retrospective study
Rami Alazab
International braz j …, 2010
View PDFchevron_right